カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗血清のグローバル市場展望 2023年-2029年：抗毒素血清、抗菌血清、抗ウイルス血清、その他

◆英語タイトル：Antiserum Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC14226）

◆商品コード：MMG23DC14226
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：103
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の抗血清市場規模と予測を収録しています。・世界の抗血清市場：売上、2018年-2023年、2024年-2029年
・世界の抗血清市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗血清市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗毒素血清」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

抗血清のグローバル主要企業は、BD、 Bio-Rad、 Shanghai Serum Bio-Technology Co., Ltd.、 China National Pharmaceutical Group、 CSL、 Merck、 BTG、 Pfizer、 Haffkine Bio-Pharmaceutical、 Vins Bioproducts、 Bharat Serums and Vaccines、 SSI Diagnostica、 GD Animal Health、 MicroPharm、 Peptide Institute Inc.、 Rare Disease Therapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、抗血清のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の抗血清市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗血清市場：タイプ別市場シェア、2022年
・抗毒素血清、抗菌血清、抗ウイルス血清、その他

世界の抗血清市場：用途別、2018年-2023年、2024年-2029年
世界の抗血清市場：用途別市場シェア、2022年
・臨床、検査

世界の抗血清市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗血清市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における抗血清のグローバル売上、2018年-2023年
・主要企業における抗血清のグローバル売上シェア、2022年
・主要企業における抗血清のグローバル販売量、2018年-2023年
・主要企業における抗血清のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
BD、 Bio-Rad、 Shanghai Serum Bio-Technology Co., Ltd.、 China National Pharmaceutical Group、 CSL、 Merck、 BTG、 Pfizer、 Haffkine Bio-Pharmaceutical、 Vins Bioproducts、 Bharat Serums and Vaccines、 SSI Diagnostica、 GD Animal Health、 MicroPharm、 Peptide Institute Inc.、 Rare Disease Therapeutics

*************************************************************

・調査・分析レポートの概要
抗血清市場の定義
市場セグメント
世界の抗血清市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗血清市場規模
世界の抗血清市場規模：2022年 VS 2029年
世界の抗血清市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗血清の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗血清製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗毒素血清、抗菌血清、抗ウイルス血清、その他
抗血清のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：臨床、検査
抗血清の用途別グローバル売上・予測

・地域別市場分析
地域別抗血清市場規模 2022年と2029年
地域別抗血清売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
BD、 Bio-Rad、 Shanghai Serum Bio-Technology Co., Ltd.、 China National Pharmaceutical Group、 CSL、 Merck、 BTG、 Pfizer、 Haffkine Bio-Pharmaceutical、 Vins Bioproducts、 Bharat Serums and Vaccines、 SSI Diagnostica、 GD Animal Health、 MicroPharm、 Peptide Institute Inc.、 Rare Disease Therapeutics
...

This research report provides a comprehensive analysis of the Antiserum market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Antiserum market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Antiserum, challenges faced by the industry, and potential opportunities for market players.
The global Antiserum market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Antiserum market presents opportunities for various stakeholders, including Clinical, Laboratory. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Antiserum market. Additionally, the growing consumer demand present avenues for market expansion.
The global Antiserum market was valued at US$ 1215.7 million in 2022 and is projected to reach US$ 2011 million by 2029, at a CAGR of 7.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
Key Features:
The research report on the Antiserum market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Antiserum market.
Market Overview: The report provides a comprehensive overview of the Antiserum market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antitoxin Serum, Antibacterial Serum), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Antiserum market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Antiserum market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Antiserum market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Antiserum market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Antiserum market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Antiserum market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Antiserum, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Antiserum market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Antiserum market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others
Market segment by Application
Clinical
Laboratory
Global Antiserum Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
BD
Bio-Rad
Shanghai Serum Bio-Technology Co., Ltd.
China National Pharmaceutical Group
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Bharat Serums and Vaccines
SSI Diagnostica
GD Animal Health
MicroPharm
Peptide Institute Inc.
Rare Disease Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiserum, market overview.
Chapter 2: Global Antiserum market size in revenue.
Chapter 3: Detailed analysis of Antiserum company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiserum in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Antiserum Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiserum Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiserum Overall Market Size
2.1 Global Antiserum Market Size: 2022 VS 2029
2.2 Global Antiserum Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antiserum Players in Global Market
3.2 Top Global Antiserum Companies Ranked by Revenue
3.3 Global Antiserum Revenue by Companies
3.4 Top 3 and Top 5 Antiserum Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antiserum Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiserum Players in Global Market
3.6.1 List of Global Tier 1 Antiserum Companies
3.6.2 List of Global Tier 2 and Tier 3 Antiserum Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Antiserum Market Size Markets, 2022 & 2029
4.1.2 Antitoxin Serum
4.1.3 Antibacterial Serum
4.1.4 Antiviral Serum
4.1.5 Others
4.2 By Type – Global Antiserum Revenue & Forecasts
4.2.1 By Type – Global Antiserum Revenue, 2018-2023
4.2.2 By Type – Global Antiserum Revenue, 2024-2029
4.2.3 By Type – Global Antiserum Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antiserum Market Size, 2022 & 2029
5.1.2 Clinical
5.1.3 Laboratory
5.2 By Application – Global Antiserum Revenue & Forecasts
5.2.1 By Application – Global Antiserum Revenue, 2018-2023
5.2.2 By Application – Global Antiserum Revenue, 2024-2029
5.2.3 By Application – Global Antiserum Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Antiserum Market Size, 2022 & 2029
6.2 By Region – Global Antiserum Revenue & Forecasts
6.2.1 By Region – Global Antiserum Revenue, 2018-2023
6.2.2 By Region – Global Antiserum Revenue, 2024-2029
6.2.3 By Region – Global Antiserum Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Antiserum Revenue, 2018-2029
6.3.2 US Antiserum Market Size, 2018-2029
6.3.3 Canada Antiserum Market Size, 2018-2029
6.3.4 Mexico Antiserum Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Antiserum Revenue, 2018-2029
6.4.2 Germany Antiserum Market Size, 2018-2029
6.4.3 France Antiserum Market Size, 2018-2029
6.4.4 U.K. Antiserum Market Size, 2018-2029
6.4.5 Italy Antiserum Market Size, 2018-2029
6.4.6 Russia Antiserum Market Size, 2018-2029
6.4.7 Nordic Countries Antiserum Market Size, 2018-2029
6.4.8 Benelux Antiserum Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Antiserum Revenue, 2018-2029
6.5.2 China Antiserum Market Size, 2018-2029
6.5.3 Japan Antiserum Market Size, 2018-2029
6.5.4 South Korea Antiserum Market Size, 2018-2029
6.5.5 Southeast Asia Antiserum Market Size, 2018-2029
6.5.6 India Antiserum Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Antiserum Revenue, 2018-2029
6.6.2 Brazil Antiserum Market Size, 2018-2029
6.6.3 Argentina Antiserum Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Antiserum Revenue, 2018-2029
6.7.2 Turkey Antiserum Market Size, 2018-2029
6.7.3 Israel Antiserum Market Size, 2018-2029
6.7.4 Saudi Arabia Antiserum Market Size, 2018-2029
6.7.5 UAE Antiserum Market Size, 2018-2029
7 Antiserum Companies Profiles
7.1 BD
7.1.1 BD Company Summary
7.1.2 BD Business Overview
7.1.3 BD Antiserum Major Product Offerings
7.1.4 BD Antiserum Revenue in Global Market (2018-2023)
7.1.5 BD Key News & Latest Developments
7.2 Bio-Rad
7.2.1 Bio-Rad Company Summary
7.2.2 Bio-Rad Business Overview
7.2.3 Bio-Rad Antiserum Major Product Offerings
7.2.4 Bio-Rad Antiserum Revenue in Global Market (2018-2023)
7.2.5 Bio-Rad Key News & Latest Developments
7.3 Shanghai Serum Bio-Technology Co., Ltd.
7.3.1 Shanghai Serum Bio-Technology Co., Ltd. Company Summary
7.3.2 Shanghai Serum Bio-Technology Co., Ltd. Business Overview
7.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Major Product Offerings
7.3.4 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue in Global Market (2018-2023)
7.3.5 Shanghai Serum Bio-Technology Co., Ltd. Key News & Latest Developments
7.4 China National Pharmaceutical Group
7.4.1 China National Pharmaceutical Group Company Summary
7.4.2 China National Pharmaceutical Group Business Overview
7.4.3 China National Pharmaceutical Group Antiserum Major Product Offerings
7.4.4 China National Pharmaceutical Group Antiserum Revenue in Global Market (2018-2023)
7.4.5 China National Pharmaceutical Group Key News & Latest Developments
7.5 CSL
7.5.1 CSL Company Summary
7.5.2 CSL Business Overview
7.5.3 CSL Antiserum Major Product Offerings
7.5.4 CSL Antiserum Revenue in Global Market (2018-2023)
7.5.5 CSL Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Antiserum Major Product Offerings
7.6.4 Merck Antiserum Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 BTG
7.7.1 BTG Company Summary
7.7.2 BTG Business Overview
7.7.3 BTG Antiserum Major Product Offerings
7.7.4 BTG Antiserum Revenue in Global Market (2018-2023)
7.7.5 BTG Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Antiserum Major Product Offerings
7.8.4 Pfizer Antiserum Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Haffkine Bio-Pharmaceutical
7.9.1 Haffkine Bio-Pharmaceutical Company Summary
7.9.2 Haffkine Bio-Pharmaceutical Business Overview
7.9.3 Haffkine Bio-Pharmaceutical Antiserum Major Product Offerings
7.9.4 Haffkine Bio-Pharmaceutical Antiserum Revenue in Global Market (2018-2023)
7.9.5 Haffkine Bio-Pharmaceutical Key News & Latest Developments
7.10 Vins Bioproducts
7.10.1 Vins Bioproducts Company Summary
7.10.2 Vins Bioproducts Business Overview
7.10.3 Vins Bioproducts Antiserum Major Product Offerings
7.10.4 Vins Bioproducts Antiserum Revenue in Global Market (2018-2023)
7.10.5 Vins Bioproducts Key News & Latest Developments
7.11 Bharat Serums and Vaccines
7.11.1 Bharat Serums and Vaccines Company Summary
7.11.2 Bharat Serums and Vaccines Business Overview
7.11.3 Bharat Serums and Vaccines Antiserum Major Product Offerings
7.11.4 Bharat Serums and Vaccines Antiserum Revenue in Global Market (2018-2023)
7.11.5 Bharat Serums and Vaccines Key News & Latest Developments
7.12 SSI Diagnostica
7.12.1 SSI Diagnostica Company Summary
7.12.2 SSI Diagnostica Business Overview
7.12.3 SSI Diagnostica Antiserum Major Product Offerings
7.12.4 SSI Diagnostica Antiserum Revenue in Global Market (2018-2023)
7.12.5 SSI Diagnostica Key News & Latest Developments
7.13 GD Animal Health
7.13.1 GD Animal Health Company Summary
7.13.2 GD Animal Health Business Overview
7.13.3 GD Animal Health Antiserum Major Product Offerings
7.13.4 GD Animal Health Antiserum Revenue in Global Market (2018-2023)
7.13.5 GD Animal Health Key News & Latest Developments
7.14 MicroPharm
7.14.1 MicroPharm Company Summary
7.14.2 MicroPharm Business Overview
7.14.3 MicroPharm Antiserum Major Product Offerings
7.14.4 MicroPharm Antiserum Revenue in Global Market (2018-2023)
7.14.5 MicroPharm Key News & Latest Developments
7.15 Peptide Institute Inc.
7.15.1 Peptide Institute Inc. Company Summary
7.15.2 Peptide Institute Inc. Business Overview
7.15.3 Peptide Institute Inc. Antiserum Major Product Offerings
7.15.4 Peptide Institute Inc. Antiserum Revenue in Global Market (2018-2023)
7.15.5 Peptide Institute Inc. Key News & Latest Developments
7.16 Rare Disease Therapeutics
7.16.1 Rare Disease Therapeutics Company Summary
7.16.2 Rare Disease Therapeutics Business Overview
7.16.3 Rare Disease Therapeutics Antiserum Major Product Offerings
7.16.4 Rare Disease Therapeutics Antiserum Revenue in Global Market (2018-2023)
7.16.5 Rare Disease Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Antiserum Market Opportunities & Trends in Global Market
Table 2. Antiserum Market Drivers in Global Market
Table 3. Antiserum Market Restraints in Global Market
Table 4. Key Players of Antiserum in Global Market
Table 5. Top Antiserum Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antiserum Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antiserum Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antiserum Product Type
Table 9. List of Global Tier 1 Antiserum Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiserum Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Antiserum Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Antiserum Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antiserum Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Antiserum Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Antiserum Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antiserum Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Antiserum Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Antiserum Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antiserum Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Antiserum Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antiserum Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Antiserum Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antiserum Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Antiserum Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antiserum Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Antiserum Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antiserum Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Antiserum Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antiserum Revenue, (US$, Mn), 2024-2029
Table 30. BD Company Summary
Table 31. BD Antiserum Product Offerings
Table 32. BD Antiserum Revenue (US$, Mn) & (2018-2023)
Table 33. BD Key News & Latest Developments
Table 34. Bio-Rad Company Summary
Table 35. Bio-Rad Antiserum Product Offerings
Table 36. Bio-Rad Antiserum Revenue (US$, Mn) & (2018-2023)
Table 37. Bio-Rad Key News & Latest Developments
Table 38. Shanghai Serum Bio-Technology Co., Ltd. Company Summary
Table 39. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product Offerings
Table 40. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue (US$, Mn) & (2018-2023)
Table 41. Shanghai Serum Bio-Technology Co., Ltd. Key News & Latest Developments
Table 42. China National Pharmaceutical Group Company Summary
Table 43. China National Pharmaceutical Group Antiserum Product Offerings
Table 44. China National Pharmaceutical Group Antiserum Revenue (US$, Mn) & (2018-2023)
Table 45. China National Pharmaceutical Group Key News & Latest Developments
Table 46. CSL Company Summary
Table 47. CSL Antiserum Product Offerings
Table 48. CSL Antiserum Revenue (US$, Mn) & (2018-2023)
Table 49. CSL Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Antiserum Product Offerings
Table 52. Merck Antiserum Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. BTG Company Summary
Table 55. BTG Antiserum Product Offerings
Table 56. BTG Antiserum Revenue (US$, Mn) & (2018-2023)
Table 57. BTG Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Antiserum Product Offerings
Table 60. Pfizer Antiserum Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Haffkine Bio-Pharmaceutical Company Summary
Table 63. Haffkine Bio-Pharmaceutical Antiserum Product Offerings
Table 64. Haffkine Bio-Pharmaceutical Antiserum Revenue (US$, Mn) & (2018-2023)
Table 65. Haffkine Bio-Pharmaceutical Key News & Latest Developments
Table 66. Vins Bioproducts Company Summary
Table 67. Vins Bioproducts Antiserum Product Offerings
Table 68. Vins Bioproducts Antiserum Revenue (US$, Mn) & (2018-2023)
Table 69. Vins Bioproducts Key News & Latest Developments
Table 70. Bharat Serums and Vaccines Company Summary
Table 71. Bharat Serums and Vaccines Antiserum Product Offerings
Table 72. Bharat Serums and Vaccines Antiserum Revenue (US$, Mn) & (2018-2023)
Table 73. Bharat Serums and Vaccines Key News & Latest Developments
Table 74. SSI Diagnostica Company Summary
Table 75. SSI Diagnostica Antiserum Product Offerings
Table 76. SSI Diagnostica Antiserum Revenue (US$, Mn) & (2018-2023)
Table 77. SSI Diagnostica Key News & Latest Developments
Table 78. GD Animal Health Company Summary
Table 79. GD Animal Health Antiserum Product Offerings
Table 80. GD Animal Health Antiserum Revenue (US$, Mn) & (2018-2023)
Table 81. GD Animal Health Key News & Latest Developments
Table 82. MicroPharm Company Summary
Table 83. MicroPharm Antiserum Product Offerings
Table 84. MicroPharm Antiserum Revenue (US$, Mn) & (2018-2023)
Table 85. MicroPharm Key News & Latest Developments
Table 86. Peptide Institute Inc. Company Summary
Table 87. Peptide Institute Inc. Antiserum Product Offerings
Table 88. Peptide Institute Inc. Antiserum Revenue (US$, Mn) & (2018-2023)
Table 89. Peptide Institute Inc. Key News & Latest Developments
Table 90. Rare Disease Therapeutics Company Summary
Table 91. Rare Disease Therapeutics Antiserum Product Offerings
Table 92. Rare Disease Therapeutics Antiserum Revenue (US$, Mn) & (2018-2023)
Table 93. Rare Disease Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Antiserum Segment by Type in 2022
Figure 2. Antiserum Segment by Application in 2022
Figure 3. Global Antiserum Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antiserum Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Antiserum Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiserum Revenue in 2022
Figure 8. By Type - Global Antiserum Revenue Market Share, 2018-2029
Figure 9. By Application - Global Antiserum Revenue Market Share, 2018-2029
Figure 10. By Type - Global Antiserum Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Antiserum Revenue Market Share, 2018-2029
Figure 12. By Application - Global Antiserum Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Antiserum Revenue Market Share, 2018-2029
Figure 14. By Region - Global Antiserum Revenue Market Share, 2018-2029
Figure 15. By Country - North America Antiserum Revenue Market Share, 2018-2029
Figure 16. US Antiserum Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Antiserum Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Antiserum Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Antiserum Revenue Market Share, 2018-2029
Figure 20. Germany Antiserum Revenue, (US$, Mn), 2018-2029
Figure 21. France Antiserum Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Antiserum Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Antiserum Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Antiserum Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Antiserum Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Antiserum Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Antiserum Revenue Market Share, 2018-2029
Figure 28. China Antiserum Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Antiserum Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Antiserum Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Antiserum Revenue, (US$, Mn), 2018-2029
Figure 32. India Antiserum Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Antiserum Revenue Market Share, 2018-2029
Figure 34. Brazil Antiserum Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Antiserum Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Antiserum Revenue Market Share, 2018-2029
Figure 37. Turkey Antiserum Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Antiserum Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Antiserum Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Antiserum Revenue, (US$, Mn), 2018-2029
Figure 41. BD Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bio-Rad Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. China National Pharmaceutical Group Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. CSL Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BTG Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Haffkine Bio-Pharmaceutical Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Vins Bioproducts Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bharat Serums and Vaccines Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. SSI Diagnostica Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. GD Animal Health Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. MicroPharm Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Peptide Institute Inc. Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Rare Disease Therapeutics Antiserum Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗血清のグローバル市場展望 2023年-2029年：抗毒素血清、抗菌血清、抗ウイルス血清、その他(Antiserum Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

抗血清のグローバル市場展望 2023年-2029年：抗毒素血清、抗菌血清、抗ウイルス血清、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp